Polyrizon Ltd. announced that it has received a notification from the Nasdaq Hearings Panel, granting the company’s request for continued listing on the Nasdaq Capital Market. This decision follows a previous delisting notice issued on May 23, 2025, which cited public interest concerns regarding substantial dilution from Series A warrants in a private placement.
The Panel's determination, issued on July 9, 2025, allows Polyrizon to maintain its listing, subject to regaining compliance with the Minimum Bid Price Rule by October 17, 2025. The company presented a plan to address Nasdaq’s concerns, including a commitment to avoid overly complex or inherently dilutive financing instruments in future capital-raising activities.
Tomer Izraeli, CEO of Polyrizon, stated that all warrants issued in the private placement have now been exercised, resulting in the issuance of 5,962,073 ordinary shares, including 5,829,389 shares from cashless exercises. This has simplified the capital structure and provided a cash balance of approximately $15.68 million, positioning the company to enhance long-term shareholder value.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.